Windtree Therapeutics Reports Year-End 2024 Financial Results and Provides Key Business Updates


WARRINGTON, Pa., April 15, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions, today reported financial results for the fiscal year ended December 31, 2024 and provided key business updates.

See original here:
Windtree Therapeutics Reports Year-End 2024 Financial Results and Provides Key Business Updates

Related Posts